
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for h... Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.17 | -6.8 | 2.5 | 2.79 | 2.2101 | 21471 | 2.53095368 | CS |
4 | -1.67 | -41.75 | 4 | 4.1002 | 2.2101 | 25014 | 2.94734185 | CS |
12 | -1.09 | -31.8713450292 | 3.42 | 5 | 2.2101 | 30810 | 3.53824922 | CS |
26 | -0.93 | -28.527607362 | 3.26 | 5.01 | 2.1501 | 27377 | 3.45169193 | CS |
52 | -5.82 | -71.4110429448 | 8.15 | 8.4 | 2.1501 | 23287 | 4.44790194 | CS |
156 | -29.47 | -92.6729559748 | 31.8 | 40.8 | 0.474 | 139843 | 17.68759395 | CS |
260 | -684.67 | -99.6608442504 | 687 | 822.3 | 0.474 | 509089 | 108.20237779 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions